Skip to main content

LIFECORE BIOMEDICAL INC DE

For the period ended Nov 7, 2024. Filed Sep 23, 2024.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Nov 7, 2024 · Filed Sep 23, 2024

LFCR$6.36-0.6%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Composition

The Audit Committee consists of the four directors whose names appear below and operates under a written charter adopted by the Board of Directors, which is available on our website at ir.lifecore.com. Each member of the Audit Committee meets the independence and financial experience requirements of the Nasdaq and the SEC currently in effect. In addition, the Board of Directors has determined that each of Mr. Edwards, Mr. Diradoorian, Ms. Houde and Matthew Korenberg is an audit committee financial expert, as defined by the rules and regulations of the SEC.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.